SPDR S&P Biotech ETF $XBI Shares Purchased by Banque Pictet & Cie SA

Banque Pictet & Cie SA boosted its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 24.1% in the fourth quarter, HoldingsChannel.com reports. The fund owned 64,877 shares of the exchange traded fund’s stock after purchasing an additional 12,595 shares during the period. Banque Pictet & Cie SA’s holdings in SPDR S&P Biotech ETF were worth $7,910,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. Compass Wealth Management LLC acquired a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at approximately $1,167,000. China Universal Asset Management Co. Ltd. increased its stake in SPDR S&P Biotech ETF by 868.3% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 4,919 shares of the exchange traded fund’s stock worth $493,000 after buying an additional 4,411 shares during the period. Ashton Thomas Private Wealth LLC acquired a new stake in SPDR S&P Biotech ETF during the 3rd quarter worth approximately $417,000. Altfest L J & Co. Inc. lifted its holdings in SPDR S&P Biotech ETF by 63.1% during the 3rd quarter. Altfest L J & Co. Inc. now owns 124,921 shares of the exchange traded fund’s stock worth $12,517,000 after buying an additional 48,326 shares in the last quarter. Finally, Brian Low Financial Group LLC purchased a new position in SPDR S&P Biotech ETF in the 3rd quarter valued at approximately $668,000.

SPDR S&P Biotech ETF Stock Up 0.6%

NYSEARCA:XBI opened at $128.55 on Thursday. The company has a fifty day simple moving average of $125.03 and a two-hundred day simple moving average of $117.89. The company has a market cap of $8.59 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 52 week low of $66.66 and a 52 week high of $132.09.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.